Atrial fibrillation: diagnosis and management
KEYWORDS: atrial, fibrillation, atrial fibrillation, committee, people, risk, evidence, recommendations, ablation, anticoagulation, stroke, treatment, bleeding, control, practice

Overview This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding. See the MHRA advice on warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic, which includes reports of supratherapeutic anticoagulation with warfarin. Who is it for? • Healthcare professionals • Commissioners and providers • People with atrial fibrillation, their families and carers Recommendations People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding. 1.1 Detection and diagnosis 1.1.1 Perform manual pulse palpation to assess for the presence of an irregular pulse if there is a suspicion of atrial fibrillation. This includes people presenting with any of the following: • breathlessness • palpitations • syncope or dizziness • chest discomfort • stroke or transient ischaemic
